Future Targeted Therapy Approaches in NSCLC

Opinion
Video

Anne S. Tsao, MD, and Edward B. Garon, MD, MS, conclude their discussion with a look to the future of TROP2 and associated targeted therapy approaches in non–small cell lung cancer.

Related Videos
Related Content